Work

CALGB 30306: A phase II study of cisplatin (C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.7563

Authors: N. Ready, A. Z. Dudek, X. F. Wang, S. Graziano, M. R. Green, E. E. Vokes

Institutions: University of Minnesota, Medical University of South Carolina, SUNY Upstate Medical University, University of Chicago, Duke Medical Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2267566363

Cites:

Cited by: 49

Related to: 10